As explained by Hugh Fatodu, RPh, MBA, current data reveal that hemophilia treatment centers provide better outcomes for patients, lower the number of emergency department visits, and decrease rates of hospitalization. Unfortunately, not all areas of the United States have access to these facilities.
Maria Lopes, MD, MS, continues the discussion by explaining that in addition to limited access to these facilities, the lack of consistency between existing hemophilia treatment centers is a major gap. Dr Lopes concludes that transparency is important when caring for patients, and that all variables that affect consistencies of the cost and value of care within these facilities need to be addressed.
And as a result of increased home-care events, Mr Fatodu also explains that there is a need to address the frequency of administration of medicines that currently affect patient adherence levels. Developing medications that have lower requirements for frequency of administration is necessary for improving patient adherence.
Michelle Petri, MD, MPH, explains that in order to eliminate these challenges a demand for research and new data is necessary. Dr Petri questions who would become responsible for paying for the research necessary to develop this new data.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More